Related Experiment Video
Updated: Jul 6, 2025

07:41
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
9.0K
Ki-67 Index and Its Correlation with Clinical and Pathological Variables in Breast Cancer
1Department of Surgical Oncology, Vydehi Institute of Medical Sciences and Research Centre, #82, EPIP Area, Nallurahalli, Whitefield, Bangalore, 560066 India.
Indian Journal of Surgical Oncology
|January 8, 2024
Summary
The Ki-67 index in breast cancer shows a significant association with tumor grade, stage, and molecular subtype. This suggests its potential role as a prognostic marker, despite no correlation with age or HER2 status.
Area of Science:
- Oncology
- Pathology
- Biomarkers
Background:
- The prognostic value of the Ki-67 index in breast cancer remains debated.
- Understanding Ki-67's associations with clinicopathological factors is crucial for accurate prognostication.
Purpose of the Study:
- To investigate the correlation between the Ki-67 index and various clinicopathological parameters in breast cancer patients.
- To assess the potential of Ki-67 as a prognostic marker in this cohort.
Main Methods:
- A prospective study of 127 female breast cancer patients (stages 1-3, nodal stage 0-1).
- Ki-67 index was correlated with age, tumor size, lymph node status, histological grade, ER, PR, HER2, and molecular subtypes.
- Statistical analysis included Chi-square and Fisher's exact tests.
Main Results:
- Ki-67 index positively correlated with pathological stage (p=0.025), grade (p=0.0001), and molecular subtype (p=0.0001).
- Inverse association observed with Estrogen Receptor (ER) (p=0.0001) and Progesterone Receptor (PR) (p=0.0001) status.
- No significant correlation found with age (p=0.892), tumor size (p=0.08), nodal status (p=0.06), or HER2 status (p=0.287).
Conclusions:
- The Ki-67 index demonstrates significant associations with key prognostic factors including grade, stage, ER, PR, and molecular subtype.
- These findings support the role of the Ki-67 index as a valuable prognostic marker in breast cancer management.
- Further research may elucidate its precise role in treatment decisions.

